Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Greg P Rubin, Villy Meineche-Schmidt, Anthony P Roberts, Susan M Childs & Niek J. de Wit. (1999) Original Paper: The management of Helicobacter pylori infection in primary care Guidelines from the ESPCG. European Journal of General Practice 5:3, pages 98-104.
Read now
Read now
R. Williamson, G. A. Pipkin, J. R. Wood. (1998) New Options in Helicobacter pylori Eradication: Efficacy, Resistance and Synergy. Scandinavian Journal of Gastroenterology 33:225, pages 36-40.
Read now
Read now
IAN L.P. BEALES. (1998) Effect of Cytokines on Acid Secretion and Gastrin Secretion in Helicobacter pylori Infection and Aspirin-Induced Gastritis. Scandinavian Journal of Gastroenterology 33:11, pages 1232-1232.
Read now
Read now
PER MARTIN KLEVELAND, HELGE L. WALDUM. (1998) Intragastric pH and Helicobacter pylori Treatment with Proton Pump Inhibitors Combined with Amoxycillin. Scandinavian Journal of Gastroenterology 33:11, pages 1230-1231.
Read now
Read now
Articles from other publishers (35)
Naoki Chiba. 2019. Evidence‐based Gastroenterology and Hepatology 4e. Evidence‐based Gastroenterology and Hepatology 4e
68
85
.
Naoki Chiba. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology
102
138
.
David Forman, Franco Bazzoli, Cathy Bennett, Nathalie Broutet, Naoki Chiba, Jonathan J Deeks, Carlo Fallone, Lori Fischbach, Richard Hunt, Raymond Lahaie, Robert Laheij, Francis Megraud, Paul Moayyedi, Giuseppina Oderda, Domenico Palli, Vincenzo Savarino, George (JJ) Misiewicz, Peter Unge, Javier P Gisbert, Ernst J Kuipers, Xavier Calvet, Adam Harris & J Q Huang. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Fernando M Silva, Jaime N Eisig, Ana Cristina S Teixeira, Ricardo C Barbuti, Tomás Navarro-Rodriguez & Rejane Mattar. (2008) Short-term triple therapy with azithromycin for Helicobacter pylori eradication: Low cost, high compliance, but low efficacy. BMC Gastroenterology 8:1.
Crossref
Crossref
Beverley J. Shea, Lex M. Bouter, Joan Peterson, Maarten Boers, Neil Andersson, Zulma Ortiz, Tim Ramsay, Annie Bai, Vijay K. Shukla & Jeremy M. Grimshaw. (2007) External Validation of a Measurement Tool to Assess Systematic Reviews (AMSTAR). PLoS ONE 2:12, pages e1350.
Crossref
Crossref
Full-Young Chang. (2005)
Response of blood endothelin-1 and nitric oxide activity in duodenal ulcer patients undergoing
Helicobacter pylori
eradication
. World Journal of Gastroenterology 11:7, pages 1048.
Crossref
Crossref
Naoki Chiba. 2004. Evidence‐based Gastroenterology and Hepatology. Evidence‐based Gastroenterology and Hepatology
83
116
.
Jia Qing HUANG, Ge Fan ZHENG, E Jan IRVINE & Johan KARLBERG. (2004) Assessing heterogeneity in meta-analyses of Helicobacter pylori infection-related clinical studies: a critical appraisal. Chinese Journal of Digestive Diseases 5:3, pages 126-133.
Crossref
Crossref
Wieslaw J. Bochenek, Suzanne Peters, Polly D. Fraga, Wenjin Wang, Michael E. Mack, Michael S. Osato, Hala M. T. El-Zimaity, Kelly D. Davis & David Y. Graham. (2003) Eradication of Helicobacter pylori by 7-Day Triple-Therapy Regimens Combining Pantoprazole with Clarithromycin, Metronidazole, or Amoxicillin in Patients with Peptic Ulcer Disease: Results of Two Double-Blind, Randomized Studies. Helicobacter 8:6, pages 626-642.
Crossref
Crossref
Nicholaos Makris, Ralph Crott, Carlo A. Fallone, Marc Bardou & Alan Barkun. (2003) Cost-effectiveness of routine endoscopic biopsies for Helicobacter pylori detection in patients with non-ulcer dyspepsia. Gastrointestinal Endoscopy 58:1, pages 14-22.
Crossref
Crossref
N L A Arents, J C Thijs & J H Kleibeuker. (2002) A rational approach to uninvestigated dyspepsia in primary care: review of the literature. Postgraduate Medical Journal 78:926, pages 707-716.
Crossref
Crossref
Fernando Marcuz Silva, Jaime Natan Eisig, Ethel Zimberg Chehter, Júlio Jovino da Silva & Antonio Atílio Laudanna. (2002) Omeprazole, Furazolidone, and Tetracycline: an eradication treatment for resistant H. pylori in Brazilian patients with peptic ulcer disease. Revista do Hospital das Clínicas 57:5, pages 205-208.
Crossref
Crossref
Fernando Marcuz Silva, Jaime Natan Eisig, Ethel Zimberg Chehter, Júlio Jovino da Silva & Antonio Atílio Laudanna. (2002) Low efficacy of an ultra-short term, once-daily dose triple therapy with omeprazole, azithromycin, and secnidazole for Helicobacter pylori eradication in peptic ulcer. Revista do Hospital das Clínicas 57:1, pages 9-14.
Crossref
Crossref
F. Bazzoli, G. Bianchi Porro, G. Maconi, M. Molteni, P. Pozzato & R.M. Zagari. (2002) Treatment of Helicobacter pylori infection. indications and regimens: an update. Digestive and Liver Disease 34:1, pages 70-83.
Crossref
Crossref
D. Boixeda de Miquel & C. Martín de Argila. (2002) Tratamiento actual de la infección por Helicobacter pylori en la enfermedad ulcerosa péptica (segunda parte). Revista Clínica Española 202:10, pages 546-548.
Crossref
Crossref
Chia-Chang Hsu, Jyh-Jou Chen, Tsung-Hui Hu, Sheng-Nan Lu & Chi-Sin Changchien. (2001) Famotidine versus omeprazole, in combination with amoxycillin and tinidazole, for eradication of Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology 13:8, pages 921-926.
Crossref
Crossref
David J. Kearney. (2001) Retreatment of Helicobacter pylori Infection After Initial Treatment Failure. American Journal of Gastroenterology 96:5, pages 1335-1339.
Crossref
Crossref
Fernando Marcuz Silva, Schlioma Zaterka, Jaime Natan Eisig, Ethel Zimberg Chehter, Décio Chinzon & Antonio Atílio Laudanna. (2001) Factors affecting Helicobacter pylori eradication using a seven-day triple therapy with a proton pump inhibitor, tinidazole and clarithromycin, in brazilian patients with peptic ulcer. Revista do Hospital das Clínicas 56:1, pages 11-16.
Crossref
Crossref
F. Bazzoli, L. Olivieri, L. De Luca, P. Pozzato, P. Lehours & F. Megraud. (2000) Therapy and drug resistance in Helicobacter pylori infection. Digestive and Liver Disease 32, pages 207-210.
Crossref
Crossref
Wei Hong Wang, Benjamin Chun Yu Wong & Shiu Kum Lam. (2001)
Pooled analysis of
Helicobacter pylori
eradication regimes in Asia
. Journal of Gastroenterology and Hepatology 15:9, pages 1007-1017.
Crossref
Crossref
David Forman, Franco Bazzoli, Cathy Bennett, Nathalie Broutet, Naoki Chiba, Jonathan J Deeks, Carlo Fallone, Lori Fischbach, Richard Hunt, Raymond Lahaie, Robert Laheij, Francis Megraud, Paul Moayyedi, Giuseppina Oderda, Domenico Palli, Vincenzo Savarino, George (JJ) Misiewicz, Peter Unge, Javier P Gisbert, Ernst J. Kuipers, Xavier Calvet, Adam Harris & J Q Huang. 1996. The Cochrane Database of Systematic Reviews. The Cochrane Database of Systematic Reviews.
Moayyedi, Feltbower, Crocombe, Mason, Atha, Brown, Dowell, Richards & Axon. (2001)
The effectiveness of omeprazole, clarithromycin and tinidazole in eradicating
Helicobacter pylori
in a community screen and treat programme
. Alimentary Pharmacology & Therapeutics 14:6, pages 719-728.
Crossref
Crossref
S.-K. Lam. 2000. Helicobacter pylori. Helicobacter pylori
559
565
.
P Marchildon, D H Balaban, M Sue, C Charles, R Doobay, N Passaretti, J Peacock, B J Marshall & D A Peura. (1999) Usefulness of Serological Igg Antibody Determinations for Confirming Eradication of Helicobacter Pylori Infection. American Journal of Gastroenterology 94:8, pages 2105-2108.
Crossref
Crossref
Paré, Farley, Romãozinho, Bardhan, French & Roberts. (2001)
Comparison of ranitidine bismuth citrate plus clarithromycin with omeprazole plus clarithromycin for the eradication of
Helicobacter pylori
. Alimentary Pharmacology & Therapeutics 13:8, pages 1071-1078.
Crossref
Crossref
Gschwantler, Dragosics, Schütze, Wurzer, Hirschl, Pasching, Wimmer, Klimpfinger, Oberhuber, Brandstätter, Hentschel & Weiss. (2001)
Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of
Helicobacter pylori
—a randomized, controlled trial
. Alimentary Pharmacology & Therapeutics 13:8, pages 1063-1069.
Crossref
Crossref
E J van der Wouden, J C Thijs, A A van Zwet, W J Sluiter & J H Kleibeuker. (1999) The Influence of in Vitro Nitroimidazole Resistance on The Efficacy of Nitroimidazole-Containing Anti- Helicobacter Pylori Regimens: A Meta-Analysis. American Journal of Gastroenterology 94:7, pages 1751-1759.
Crossref
Crossref
Sieg, Sellinger, Schlauch, HÖrner & Fuchs. (2001)
Short‐term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate
Helicobacter pylori
. Alimentary Pharmacology & Therapeutics 13:7, pages 865-868.
Crossref
Crossref
Teresa Alarcón, Diego Domingo & Manuel López-Brea. (1999) Antibiotic resistance problems with Helicobacter pylori. International Journal of Antimicrobial Agents 12:1, pages 19-26.
Crossref
Crossref
LEE, BRESLIN, HYDE, BUCKLEY & O'MORAIN. (2001)
Treatment options for
Helicobacter pylori
infection when proton pump inhibitor‐based triple therapy fails in clinical practice
. Alimentary Pharmacology & Therapeutics 13:4, pages 489-496.
Crossref
Crossref
IPKIN, ILLIAMSON & OOD. (2001) Reply—clarithromycin‐based triple therapies. Alimentary Pharmacology & Therapeutics 13:3, pages 438-439.
Crossref
Crossref
Ahuja, Dhar, Bal & Sharma. (2001)
Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of
Helicobacter pylori
in a developing country
. Alimentary Pharmacology & Therapeutics 12:6, pages 551-555.
Crossref
Crossref
SK LAM & NJ TALLEY. (1998) Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 13:1, pages 1-12.
Crossref
Crossref
Nobuyuki Shimizu, Michio Kaminishi, Masae Tatematsu, Eiichi Tsuji, Akemi Yoshikawa, Hirokazu Yamaguchi, Fumio Aoki & Takeshi Oohara. (1998) Helicobacter pylori promotes development of pepsinogen-altered pyloric glands, a preneoplastic lesion of glandular stomach of BALB/c mice pretreated with N-methyl-N-nitrosourea. Cancer Letters 123:1, pages 63-69.
Crossref
Crossref
G. Treiber, S. Ammon & U. Klotz. (1997) Age-dependent eradication of Helicobacter pylori with dual therapy. Alimentary Pharmacology and Therapeutics 11:4, pages 711-718.
Crossref
Crossref